The impact of clinical pharmacists on adherence to acute myocardial infarction guidelines: A controlled before-after Interventional study

Abstract

In this controlled before-and-after interventional study, the clinical pharmacist evaluated the application of performance measures (PMs) and quality measures (QMs) in the control group and the intervention group in Al-Gurayat General Hospital (GGH) in Saudi Arabia. The total number of PMs applied in the intervention group (n = 445) was significantly higher than that in the control group (n = 407) (P-value =0.006). Considering individual PMs, only PM-4 (high-intensity statin prescription) was applied at a significantly higher frequency in the intervention group (n = 41, 82%) as compared to the control group (n = 29, 58%) (P-value = 0.009). After acceptance of 60 out of the 75 recommendations made by the clinical pharmacist for the intervention group (80% acceptance rate), the number of treatment-related problems (TRPs) left on discharge of the intervention group was significantly reduced to 15 as compared to 61 TRPs left on discharge of the control group (p <0.001). The clinical pharmacist-led interventions have a significant impact on ensuring adherence to PMs during the management of acute myocardial infarction (AMI) in GGH.